Immunic (NASDAQ:IMUX) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Immunic (NASDAQ:IMUX – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the stock. Separately, Wedbush reiterated an outperform rating and issued a $5.00 price objective on shares of Immunic in a report on Tuesday, January 31st. One investment […]